Ensysce Biosciences Inc (ENSC) Live Share Price, Invest From India

Ensysce Biosciences Inc Stock Performance

as on May 14, 2026 at 4:11 am IST

Day's Low
Day's High
$0.28
Day's Price Range
$0.31
$0.29
3.45%
Downside
6.90%
Upside
52 Week's Low
52 Week's High
$0.30
52-Week Price Range
$2.75
$0.29
-3.79%
Downside
848.28%
Upside

Ensysce Biosciences Inc share price movements today

Previous Close: $0.32
Open: $0.29
Volume: 1.2M
Day's Low - High: $0.28 - $0.31
52 Week Low - High: $0.30 - $2.75

Ensysce Biosciences Inc Historical Returns

1 Month Return: -42.58 %
3 Month Return: -27.24 %
1 Year Return: -84.71 %
3 Year Return: -99.33 %
5 Year Return: 0 %

Ensysce Biosciences Inc Stock Fundamentals & Key Indicators

Check Ensysce Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5M

EPS (TTM)

-3.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-10.2M

Revenue (TTM)

5.1M

Profit Margin

-200.84%

Return On Equity TTM

-324.88%

Ensysce Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ensysce Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ensysce Biosciences Inc	BUY	$3.5M	NA	NA	-200.84%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	119.7%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	109.14%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	39.88%	17.39	29.65%

Stock Returns calculator for Ensysce Biosciences Inc Stock including INR - Dollar returns

The Ensysce Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Ensysce Biosciences Inc investment value today

Current value as on today

₹15,723

Returns

-₹84,277

(-84.28%)

Returns from Ensysce Biosciences Inc Stock

-₹85,990 (-85.99%)

Dollar Impact

₹1,714 (+1.71%)

Analyst Recommendation on Ensysce Biosciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Ensysce Biosciences Inc. Average target price of $16.45

Ensysce Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Ensysce Biosciences Inc.

What analysts predicted

98.24%UPSIDE

Target Price

$16.45

Current Price

$0.29

Analyzed by

7 Analysts

Target

$16.45

Ensysce Biosciences Inc target price $16.45, a slight upside of 98.24% compared to current price of $0.29. According to 7 analysts rating.

Indian Investors' Interest in Ensysce Biosciences Inc Stock

Search interest for Ensysce Biosciences Inc Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:20% versus previous 30 day period

Ensysce Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	0	0	3	1	1	1	0	1
Gross Profit	-1	-1	0	0	1	-2	1	0	-2	-
Operating Income	-2	-3	-1	-1	0	-3	-1	-1	-3	-2
EBITDA	-2	-3	-1	-1	0	-3	-1	-1	0	-2
Interest Expense	0	0	1	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-3	-3	-1	0	-3	-1	-1	-3	-2
Income Tax Expense	0	0	0	0	-	0	-	-	-	-
Net Income	-2	-3	-3	-1	0	-3	-1	-1	-3	-2
Net Profit Margin	-617.75%	-680.23%	-1019.23%	-1082.41%	19.36%	-273.42%	-147.42%	-126.39%	-756.26%	-147.05%

Ensysce Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	1	3	3	2	2	5	5
Gross Profit	-	-1	-3	3	3	-17	-5	-2	-
Operating Income	0	0	-3	-1	-19	-24	-10	-6	-10
EBITDA	0	0	-3	0	-19	-24	-10	-6	-10
Interest Expense	-	-	-	0	1	0	0	1	0
Depreciation	-	-	-	0	0	-	-	-	0
Income Before Tax	0	2	0	0	-29	-24	-10	-7	-10
Income Tax Expense	0	0	0	0	0	0	0	-	-
Net Income	0	2	1	0	-29	-24	-10	-7	-10
Net Profit Margin	0.00%	0.00%	83.70%	1.44%	-825.38%	-989.21%	-475.71%	-153.30%	-200.84%

Ensysce Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-3	-3	-1	0	-3	-1	-1	-3	-5
Operating Cash Flow	-1	-3	-2	-1	0	-1	-2	-1	-1
Investing Cash Flow	-	-	-	-	-	-	-	0	0
Financing Cash Flow	1	5	0	4	0	1	1	1	4
Change in Cash	0	2	-2	3	0	0	0	0	2

Ensysce Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	0	0	-29	-24	-10	-7	-10,176,187
Operating Cash Flow	-1	10	-1	-8	-17	-10	-7,502,700	-7,806,292
Investing Cash Flow	0	0	183	-	0	-	-	-123,643
Financing Cash Flow	0	-11	1	20	8	8	9,881,173	8,738,212
Change in Cash	0	0	0	12	-9	-2	2,378,473	808,277

Global Institutional Holdings in Ensysce Biosciences Inc

Funds	Holdings
FNY Investment Advisers, LLC	0.03%
Genworth Financial Wealth Mgmt Inc	0%
Morgan Stanley - Brokerage Accounts	0%
Renaissance Technologies Corp	0%
Murchinson Ltd.	0%

See all

Insights on Ensysce Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 493.10K → 1.88M (in $), with an average increase of 73.8% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.72M → -2.76M (in $), with an average increase of 34.7% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 131.5%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 124.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ENSC stock has moved down by -18.8%

About Ensysce Biosciences Inc

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat opioid use disorder. Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.

Organisation	Ensysce Biosciences Inc
Headquarters	7946 Ivanhoe Avenue, La Jolla, CA, United States, 92037
Industry	Biotechnology
CEO	Dr. D. Lynn Kirkpatrick Ph.D.
E-voting on shares	Click here to vote

Key Management of Ensysce Biosciences Inc

Name	Title
Dr. Jeffrey Millard Ph.d.	Chief Operating Officer
Dr. William K. Schmidt Ph.D.	Chairman of Clinical Advisory Board & Chief Medical Officer
Dr. Linda Pestano Ph.D.	Chief Development Officer
Dr. D. Lynn Kirkpatrick Ph.D.	President, CEO & Director
Mr. David C. Humphrey CPA	CFO, Secretary & Treasurer
Mr. Geoffrey Birkett	Chief Commercial Officer

FAQs

What is Ensysce Biosciences Inc share price today?

Ensysce Biosciences Inc share price today is $0.29 as on May 13, 2026 at 10:41 pm IST. Ensysce Biosciences Inc share today touched a day high of $0.31 and a low of $0.28.

What is the 52 week high and 52 week low for Ensysce Biosciences Inc share?

Ensysce Biosciences Inc share touched a 52 week high of $2.75 on October 16, 2025 and a 52 week low of $0.3 on May 11, 2026. Ensysce Biosciences Inc stock price today i.e. May 13, 2026 at 10:41 pm IST is trending at $0.29,which is 89.45% down from its 52 week high and -3.65% up from its 52 week low.

What is Ensysce Biosciences Inc's market capitalisation today?

Ensysce Biosciences Inc market capitalisation is $0.00T as on May 13, 2026 at 10:41 pm IST.

How to invest in Ensysce Biosciences Inc Stock (ENSC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ensysce Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ensysce Biosciences Inc Shares that will get you 5.1724 shares as per Ensysce Biosciences Inc share price of $0.29 per share as on May 13, 2026 at 10:41 pm IST.

What is the minimum amount required to buy Ensysce Biosciences Inc Stock (ENSC) from India?

Indian investors can start investing in Ensysce Biosciences Inc (ENSC) shares with as little as ₹95.705 or $1 (as of May 13, 2026 at 10:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Ensysce Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 10:41 pm IST). Based on Ensysce Biosciences Inc share’s latest price of $0.29 as on May 13, 2026 at 10:41 pm IST, you will get 34.4828 shares of Ensysce Biosciences Inc. Learn more about fractional shares .